OneBio Venture Studio

OneBio leverages strategic partnerships with the Cape Innovation & Technology Initiative and the Centre for Proteomic & Genomic Research to access academic and early-stage applied research. Its physical Innovation Centre attracts startups needing lab space, creating a proprietary pipeline of tenant companies that can be evaluated for venture funding. The firm's membership in SAVCA and founders' Singularity University network provide additional referral channels.

The Seed Investment Fund is a formal vehicle co-managed with the SA SME Fund and the Technology Innovation Agency. It handles direct equity investments from OneBio's portfolio, while the broader venture studio provides operational support and access to lab infrastructure. The fund structure institutionalizes what would otherwise be a balance sheet investment program, allowing for clear governance between the public and private partners.

OneBio's mandate covers biotechnology broadly, with an emphasis on healthcare and agricultural applications. Confirmed portfolio company Altera Biosciences indicates a focus on life science tools and molecular biology. The agricultural orientation aligns with South Africa's economic strengths and the government-backed TIA's interest in food security innovation.

The firm's venture studio model implies a high degree of hands-on involvement, but specific check-size and lead versus follow dynamics remain undisclosed. The OneBio Seed Investment Fund's collaboration with the SA SME Fund and TIA suggests a lead or co-lead capacity in seed rounds, as dedicated fund partnerships typically carry decision-making authority over their capital. Direct evidence of lead investor roles in named rounds is not publicly available.

Both OneBio Venture Studio and BioCityLabs are linked to founder Dr. Nick Walker. While OneBio provides venture capital and incubation services from its Innovation Centre in Salt River, BioCityLabs appears to be an additional industrial asset offering specialized laboratory space in Cape Town. The overlapping leadership and geographic proximity indicate a coordinated, multi-site infrastructure strategy for life science startups, though the precise ownership structure between them is not publicly detailed.